DDTL 1.0
$1.3B
SOFR margin not restated in this 10-Q H1 table · Effective 15%
RATE SENSITIVITY · COREWEAVE (CRWV) · AS-OF JUN 30, 2026 · FILED AUG 11–12, 2026
CoreWeave’s Q2 2026 10-Q Item 3 says a +100 bp move on outstanding floating-rate debt lifts interest expense by ~$30M over three months — ~$120M/year if you annualize. Floating principal is ~$12.2B of $35.6B total. Interest expense, net already ate 24.9% of Q2 revenue; +100 bp pushes that to ~26%. Companion to Bank of NVDA — the canary’s rate bill, not a tip sheet.
01 · PRINCIPAL SPLIT
Itemized floating ~$12.2B (DDTL 1.0–3.0 + 5.0 + DDTL 4.0 float). Item 3 check ≈ $12.0B–$12.2B. Fixed / converts / OEM / other ≈ $23.3B–$23.4B of $35.6B total future principal (Note 10).
DDTL 1.0
SOFR margin not restated in this 10-Q H1 table · Effective 15%
DDTL 2.0
SOFR margin not restated in this 10-Q H1 table · Effective 11%
DDTL 2.1
SOFR margin not restated in this 10-Q H1 table · Effective 9%
DDTL 3.0
SOFR margin not restated in this 10-Q H1 table · Effective 9%
DDTL 5.0
SOFR + 4.50% · Effective 9%
DDTL 4.0 float
SOFR + 2.25% · Non-recourse SPV tranche
FLAG Older DDTL 1.0–3.0 SOFR margins are not restated in this 10-Q’s H1 issuance table. Treating them as floating is supported by Item 3’s aggregate sensitivity matching their sum + DDTL 4.0 float + DDTL 5.0 — but do not invent those margins here.
02 · INTEREST BITE VS REVENUE
Q2 revenue $2,575M. Interest expense, net $640M(P&L line — prefer over Note 10 debt interest after cap of $558M). Bars use annualized P&L interest (×4) plus shock.
As filed
~$2,560M/yr interest (run-rate)
24.9% of Q2 revQ interest ~$640M
Item 3
~$2,680M/yr interest (run-rate)
26.0% of Q2 revQ interest ~$670M
Derived
~$2,800M/yr interest (run-rate)
27.2% of Q2 revQ interest ~$700M · derived
DERIVED +200 bp ≈ $240M/year is not company-disclosed — linear 2× the Item 3 +100 bp annualization only. Swaps notional $4.66B “intended to mitigate” floating risk; Item 3 is on outstanding floating balance, not hedge-adjusted. Hedge benefit for +100 bp is not quantified.
03 · METHOD
Plain English. Same arithmetic the company implies in Item 3.
STEP 1
~$12.2B itemized (or ~$12.0B–$12.2B from Item 3’s $30M / quarter ÷ 0.25% = $12.0B check).
STEP 2
One percentage point on $12.2B ≈ $122M/year. Company Item 3 annualizes to ~$120M ($30M × 4) — same order of magnitude.
STEP 3
Q2 interest expense, net $640M / revenue $2,575M = 24.9%. Add $30M → 26%.
LIMITS
Not hedge-adjusted. Not +200 bp from the company. Not post–Jun 30 draws (see subsequent events). Not a forecast of SOFR.
04 · REFINANCE WALL
Note 10 future principal payments. Rem. 2026 $4.4B + 2027 $6.2B. Coupons where the filing states them.
| Instrument | Coupon / rate (stated) | Principal |
|---|---|---|
| DDTL 5.0 | SOFR + 4.50% | $1.1B |
| DDTL 4.0 float | SOFR + 2.25% | $1.4B |
| DDTL 4.0 fixed | Treasury + 2.00% | $1.5B |
| 2031 Senior Notes | 9.00% | $1.8B |
| 2031 Senior Notes | 9.75% | $2.8B |
| 2032 Senior Notes | 9.625% | $1.3B |
| 2032 EUR Senior Notes | 8.50% | $2.3B |
| 2032 Convertible SN | 1.75% (eff. ~2%) | $4.0B |
| OEM short-term WA | ~9% | — |
05 · SUBSEQUENT EVENTS
Same 10-Q subsequent-events language. These increase drawn / floating exposure after the balance sheet date — do not fold into the ~$12.2B Jun 30 floating figure.
DDTL 5.5
$1.2B drawn · Term SOFR + 5.5% · $2.6B facility · matures Sep 2031 · Aug 2026
Revolver
$1.2B drawn in Aug 2026 (was $0 drawn at Jun 30)
06 · CROSS-READS
Rate bill meets financed CapEx.
07 · SOURCES / FOOTNOTES
Filed Aug 11–12, 2026. Accession 0001769628-26-000366. No invented covenants or margins.
This page is analysis for Bubble Burster — not investment advice. +200 bp and annualized +100 bp beyond Item 3’s quarterly/half-year figures are labeled derived. Hedge-adjusted sensitivity is not disclosed. P&L interest expense, net ($640M) ≠ Note 10 debt interest after capitalized interest ($558M); the gap may include finance-lease interest and other financing costs. Always re-read the latest filing.